Latest 10-K annual reports

Tecnoglass Inc. reported a 10.5% increase in operating revenue for 2025, driven by U.S. commercial and residential market activity, alongside strategic acquisitions and investments in technology.

JBT Marel Corporation announced its 2025 annual results, highlighting significant revenue growth driven by the Marel acquisition and strategic realignment into two new segments.

Pagaya Technologies Ltd. achieved significant profitability in 2025 with $81.4 million in net income, a substantial improvement from a $401.4 million loss in 2024, driven by robust revenue growth and operational efficiencies.

UroGen Pharma's 2025 annual report details significant revenue growth driven by Jelmyto and Zusduri sales, alongside pipeline advancements and increased operating losses.

Millrose Properties, Inc. reports significant growth in its first year as an independent public company, driven by its homesite option platform and strategic acquisitions, achieving $379.9 million in net income.

uniQure N.V. reported positive topline data for its lead Huntington's disease gene therapy, AMT-130, but the FDA deemed the current Phase I/II data insufficient for a Biologics License Application (BLA) submission, recommending a randomized, double-blind, sham surgery-controlled study.

Dyne Therapeutics reports significant clinical progress for DMD and DM1 programs, secures substantial financing, and expands its pipeline for genetically driven neuromuscular diseases.

Apogee Therapeutics' 2025 annual report highlights positive clinical trial data for lead programs in atopic dermatitis and asthma, alongside significant capital raises to fund pipeline development.

Sionna Therapeutics, a clinical-stage biopharmaceutical company, reported a net loss of $75.3 million for 2025 while advancing its lead cystic fibrosis product candidates, SION-719 and SION-451, into later-stage clinical trials.

Steven Madden, Ltd. reported an 11.0% revenue increase in 2025, primarily driven by the Kurt Geiger acquisition, though net income and diluted EPS declined significantly amidst tariff impacts and acquisition-related costs.

Geron Corporation reported a significant reduction in net losses for 2025, driven by initial RYTELO sales, while navigating ongoing legal proceedings and a strategic workforce reduction.

GT Biopharma, a clinical-stage biopharmaceutical company, reported a significant net loss and substantial doubt about its ability to continue as a going concern, despite advancing its TriKE product pipeline.

AAON, Inc. reported a 20.1% increase in net sales for 2025 driven by robust demand for BASX-branded data center cooling solutions, despite a decline in AAON-branded product sales and operational disruptions from an ERP system implementation.

Sarepta Therapeutics reported a significant net loss of $713.4 million in 2025, driven by increased R&D expenses for new collaborations and substantial inventory write-offs, alongside critical safety updates for ELEVIDYS and a primary endpoint miss in the ESSENCE trial.

Biglari Holdings Inc. reported a net loss of $37.488 million for fiscal year 2025, primarily driven by significant losses in investment partnerships, despite revenue growth in restaurant and insurance segments.

Venture Global, Inc. reported significant revenue and operational growth in 2025, driven by increased LNG production and project advancements, but faces escalating debt, interest costs, and multi-billion dollar legal disputes.

Zymeworks Inc. reports a net loss of $81.1 million for 2025, alongside significant regulatory approvals for zanidatamab and a new $250 million royalty financing deal.

UnitedHealth Group Incorporated announced a significant decline in 2025 operating earnings, driven by elevated medical costs and substantial restructuring charges, despite overall revenue growth.

EchoStar Corporation is undergoing a major strategic shift, selling substantial wireless spectrum to AT&T and SpaceX for approximately $42.65 billion in response to FCC pressure, while reporting a $17.6 billion impairment charge and a going concern warning.

Natural Resource Partners L.P. experienced a significant decline in revenues, net income, and cash flow in 2025, primarily due to weak coal and soda ash markets, leading to suspended distributions from its Sisecam Wyoming joint venture.

Forum Energy Technologies reports a 3.1% revenue decrease in 2025 to $791.5 million, driven by challenging market conditions and tariff impacts, despite growth in ROV projects and coiled line pipe sales.

Armada Hoffler Properties, Inc. reports a strategic repositioning to streamline operations, focusing on retail and office properties while divesting its multifamily, construction, and real estate financing segments.

Banc of California delivered significantly improved financial results in 2025, driven by increased net interest income, reduced expenses, and strategic balance sheet repositioning.

CVB Financial Corp. reported increased net earnings and improved net interest margin for fiscal year 2025, while progressing with its all-stock merger with Heritage Commerce Corp.

Global Industrial Company reported a 4.8% revenue increase to $1.38 billion in 2025, alongside improved margins and operating income, despite identifying material weaknesses in internal controls at its Indoff LLC subsidiary.

Stewart Information Services Corporation reported significant financial growth in 2025, driven by strong title and real estate solutions segments, alongside a major acquisition.

NBT Bancorp Inc. announced a significant increase in net income and assets for 2025, driven by the strategic acquisition of Evans Bancorp and robust loan and deposit growth.

Warner Bros. Discovery reported a significant turnaround in net income for 2025, driven by streaming growth and debt reduction, while announcing a definitive merger agreement with Paramount Skydance Corporation.

Byline Bancorp, Inc. reported a 7.7% increase in net income to $130.1 million for 2025, driven by loan growth and a strategic acquisition, despite rising credit loss provisions.

Zoom Communications, Inc. reported a significant increase in net income for fiscal year 2026, driven by strong Enterprise customer growth and strategic AI investments, despite a moderating revenue growth rate.